ALGS icon

Aligos Therapeutics
ALGS

Overview Fund Activity

52 hedge funds and large institutions have $30.4M invested in Aligos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 12 closing their positions.

Holders
52
Holders Change
-7
Holders Change %
-11.86%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
12
Reduced
17
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TCM
1
Tang Capital Management
California
$1.84M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.01M
3
Rockefeller Capital Management
3
Rockefeller Capital Management
New York
$85K
4
NM
4
Newtyn Management
New York
$1.1M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.2M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$804K
3
Millennium Management
3
Millennium Management
New York
$365K
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$35K
5
Citadel Advisors
5
Citadel Advisors
Florida
$80K
Name Holding Trade Value Shares
Change 		Shares
Change %
TLP
51
Tri Locum Partners
New York
– -$35K -1,172 Closed
AI
52
Atom Investors
Texas
– -$27K -907 Closed
WPC
53
Wedmont Private Capital
Pennsylvania
– -$25K -830 Closed
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
– -$19K -641 Closed
EMG
55
ETF Managers Group
New Jersey
– -$17K -540 Closed
HTC
56
Hershey Trust Company
Pennsylvania
– -$6K -182 Closed
Barclays
57
Barclays
United Kingdom
– -$4K -117 Closed
1 2
3